s-adenosylmethionine has been researched along with Cancer of Prostate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bovet, C; Gray, PC; Kruithof-de Julio, M; Minoli, M; Ng, CKY; Piscuoglio, S; Spahn, M; Thalmann, GN; Wehrhan, A; Zoni, E | 1 |
| Beger, RD; Cao, Z; Nakamura, N; Pence, LM | 1 |
| Boeing, H; Floegel, A; Johnson, T; Kaaks, R; Kühn, T; Otto, W; Rolle-Kampczyk, U; Sookthai, D; von Bergen, M | 1 |
| Schmidt, T | 1 |
| Dobreva, G; Duman, MB; Mathes, A; Neumann, A; Schmidt, T | 1 |
| Alimonti, A; Anguita, J; Aransay, AM; Arreal, L; Arruabarrena-Aristorena, A; Astobiza, I; Azkargorta, M; Bago, R; Barnett, A; Barrio, R; Baselga, J; Beraza, N; Cabrera, D; Caro-Maldonado, A; Carracedo, A; Castillo-Martín, M; Castro, E; Cendon, Y; Clasquin, M; Cordon-Cardo, C; Cortazar, AR; Efeyan, A; Elortza, F; Falcón-Pérez, JM; Farràs, R; Fernandez-Dominguez, I; Fernandez-Ruiz, S; Gentilella, A; Jimenez, J; Lacasa-Viscasillas, I; Lein, G; Loizaga-Iriarte, A; Macarulla, T; Manning, BD; Marjon, K; Marks, K; Martín-Martín, N; Martinez-Chantar, ML; Mato, JM; Muñoz, J; Murray, S; Nuciforo, P; Olmos, D; Pirman, D; Piva, M; Prudkin, L; Quang, P; Revandkar, A; Sánchez-Mosquera, P; Serra, V; Sutherland, JD; Tabernero, J; Thomas, G; Tomas-Cortazar, J; Torrano, V; Torres, I; Ugalde-Olano, A; Unda, M; Valcarcel-Jimenez, L; van Liempd, SM; Ximenez-Embun, P; Zabala-Letona, A; Zhang, Y; Zuñiga-García, P | 1 |
| Badur, MG; Beltran, H; Bhangoo, MS; Cordes, T; Diaz-Meco, MT; Duran, A; Eng, K; Garcia-Olmo, DC; L'Hermitte, A; Linares, JF; Metallo, CM; Moscat, J; Nam-Cha, SY; Reina-Campos, M; Richards, A; Rooslid, T; Salinas-Sanchez, AS; Scott, DA; Thorson, PK | 1 |
| Arakelian, A; Chik, F; Parashar, S; Rabbani, SA; Shukeir, N; Stefanska, B; Szyf, M | 1 |
| Leha, A; Salinas-Riester, G; Schmidt, T | 1 |
| Campbell, MJ; Long, MD; Smiraglia, DJ | 1 |
| Basu, HS; Bhattacharya, S; Frydman, B; Kisiel, N; Marton, LJ; Maxuitenko, Y; Porter, CW; Reddy, VK; Sarkar, A; Valasinas, A | 1 |
| Diegelman, P; Kee, K; Kisiel, N; Kramer, DL; Merali, S; Porter, CW; Powell, CT; Vujcic, S | 1 |
| Chen, G; Pakneshan, P; Rabbani, SA; Shukeir, N; Szyf, M | 1 |
| Estes, N; Patel, J; Pulukuri, SM; Rao, JS | 1 |
1 review(s) available for s-adenosylmethionine and Cancer of Prostate
| Article | Year |
|---|---|
The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
Topics: CpG Islands; Databases, Genetic; DNA Methylation; Epigenomics; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic Predisposition to Disease; Humans; Male; Prostatic Neoplasms; S-Adenosylmethionine | 2017 |
13 other study(ies) available for s-adenosylmethionine and Cancer of Prostate
| Article | Year |
|---|---|
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
Topics: Aged; Carnitine; Case-Control Studies; Chromatography, Liquid; Disease Progression; Fatty Acids; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Prognosis; Prostatic Neoplasms; White People | 2019 |
Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones.
Topics: Amino Acids; Animals; Biomarkers; Carnitine; Estradiol; Glycerophospholipids; Glycine; Gonadal Steroid Hormones; Humans; Inflammation; Lipids; Male; Metabolomics; Plasma; Prostatic Neoplasms; Prostatitis; Rats; Rats, Sprague-Dawley; Sphingomyelins | 2020 |
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carnitine; Cohort Studies; Colorectal Neoplasms; Female; Humans; Lipid Metabolism; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Neoplasms; Prospective Studies; Prostatic Neoplasms | 2016 |
S-Adenosylmethionine affects ERK1/2 and STAT3 pathway in androgen-independent prostate cancer cells.
Topics: Androgens; Apoptosis; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Prostatic Neoplasms; S-Adenosylmethionine; STAT3 Transcription Factor | 2022 |
S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
Topics: DNA Methylation; Histones; Humans; Male; Methylation; Prostatic Neoplasms; Protein Processing, Post-Translational; S-Adenosylmethionine | 2024 |
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Topics: Adenosylmethionine Decarboxylase; Animals; Cell Proliferation; Enzyme Activation; Everolimus; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Metabolomics; Mice; Multiprotein Complexes; Phosphatidylinositol 3-Kinases; Polyamines; Prostatic Neoplasms; Protein Stability; PTEN Phosphohydrolase; S-Adenosylmethionine; TOR Serine-Threonine Kinases | 2017 |
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.
Topics: Activating Transcription Factor 4; Biosynthetic Pathways; Carcinoma, Neuroendocrine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Male; Mechanistic Target of Rapamycin Complex 1; Prostatic Neoplasms; Protein Kinase C; S-Adenosylmethionine; Serine | 2019 |
Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Male; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Neoplasms; S-Adenosylmethionine; Tibia; X-Ray Microtomography | 2015 |
Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles.
Topics: Cell Movement; Cell Proliferation; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Mas; S-Adenosylmethionine; Sequence Analysis, RNA; Sulfites; Tumor Cells, Cultured | 2016 |
A novel polyamine analog (SL-11093) inhibits growth of human prostate tumor xenografts in nude mice.
Topics: Acetyltransferases; Animals; Antineoplastic Agents; Biogenic Polyamines; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Ornithine Decarboxylase; Polyamines; Prostatic Neoplasms; S-Adenosylmethionine; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells.
Topics: Acetyl Coenzyme A; Acetyltransferases; Adenosylmethionine Decarboxylase; Carcinoma; Cell Division; Deoxyadenosines; Eflornithine; Enzyme Inhibitors; Humans; Male; Methionine; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; Polyamines; Prostatic Neoplasms; Putrescine; RNA, Messenger; S-Adenosylmethionine; Tetracyclines; Thionucleosides; Tumor Cells, Cultured | 2004 |
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Genetic Therapy; Humans; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neovascularization, Pathologic; Oligonucleotides, Antisense; Plasminogen Activators; Prostatic Neoplasms; RNA, Messenger; S-Adenosylmethionine; Transfection; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2006 |
Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
Topics: Cell Growth Processes; Disease Progression; DNA Methylation; Enzyme Activation; Humans; Male; Neoplasm Invasiveness; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; S-Adenosylmethionine; Urokinase-Type Plasminogen Activator | 2007 |